NASDAQ$BTTC

Black Titan Corp · Q1 2018 earnings

Q1 2018 earnings · · Investor relations

Headline financials

Total Revenue

$634K

Previous: $40K+1486.1%
EPS (adj)

-$432.00

Previous: -$576.00+25.0%
Capital Expenditures

$58K

Previous: $26K+123.1%
Free Cash Flow

-$1.06M

Previous: -$3.14M+66.3%
Net Income

$90.3K

Previous: -$3.01M+103.0%
Operating Income

$104K

Previous: -$3.44M+103.0%
Gross Profit

$441K

Previous: -$2.09M+121.1%
Cash & Equivalents

$57.9K

Previous: $10.9M-99.5%
Total Assets

$4.03M

Previous: $13.1M-69.2%
Stock-Based Comp

$432K

Previous: $421K+2.6%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$634K

Q1 2018+1,486.1%vs Q1 2017
Beat estimate in 6 of 13 quarters(46%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro